Chinese Journal of Pharmaceuticals
|
2022, 53(4): 572-577
• Pharmaceutical Management & Information •
Regulatory Requirements, Common Defects and Regulatory Considerations for Drug Manufacturing Technology Transfer
Full
Qing LI
1, Lihua WU
2, Yuanyuan GE
3, *
Affiliations
- 1.Chongqing Center for Drug Evaluation & Inspection, Chongqing 401120
- 2.Shandong Center for Food and Drug Evaluation & Inspection, Jinan 250014
- 3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
Published: 2022-04-10
doi: 10.16522/j.cnki.cjph.2022.04.022
Outline
李青, 毋立华, 葛渊源.
药品生产技术转移法规要求、常见问题与监管考量.
中国医药工业杂志,
2022
, 53
(4)
: 572
-577
.
DOI: 10.16522/j.cnki.cjph.2022.04.022
Qing LI, Lihua WU, Yuanyuan GE.
Regulatory Requirements, Common Defects and Regulatory Considerations for Drug Manufacturing Technology Transfer[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(4)
: 572
-577
.
DOI: 10.16522/j.cnki.cjph.2022.04.022
Year 2022 volume 53 Issue 4
70
16
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.04.022
- Receive Date:2021-12-29
- Online Date:2026-11-12
- Published:2022-04-10